'The weaponization of AI is just beginning'

'The embrace between Big Tech and Big Government is growing tighter'

John Mac Ghlionn at Newsweek

With the appointment of retired General Paul Nakasone to its board, OpenAI made a major shift in "alignment toward national security issues, a development that should concern us all," says John Mac Ghlionn. Tech giants like Amazon, Google and Microsoft have "increasingly aligned themselves with governmental and military agendas under the guise of 'security' and 'keeping Americans safe.'" But in reality, these platforms have "gradually transformed into tools of surveillance and control." 

Read more

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

'Without Yale Law School, there could be no phenomenon of JD Vance'

Noah Feldman at Bloomberg 

Yale Law's program has played a "vital role in legal conservatism," says Noah Feldman, producing Supreme Court Justices Clarence Thomas, Samuel Alito and Brett Kavanaugh, plus Trump's VP candidate, J.D. Vance. "Admission to Yale was his main accomplishment when he wrote his best-selling memoir, 'Hillbilly Elegy,'" says Feldman. "It framed Vance as an effective source to 'explain' poor white politics" to the public. Yale Law is largely liberal, and these politicians' "rarity is doubtless one reason Yale Law conservatives ascend so quickly."  

Read more

'Granting approval to this questionable therapy cannot become the norm'

Liam Bendicksen, Edward Cliff and Aaron S. Kesselheim at The Washington Post

The Food and Drug Administration (FDA) has frequently fallen short of ensuring that approved drugs are effective, say Liam Bendicksen, Edward Cliff and Aaron S. Kesselheim. The FDA recently approved Elevidys to treat Duchenne muscular dystrophy, but the "drug did not demonstrate a clear benefit for patients," and "giving full FDA validation to a drug with exceedingly limited and uncertain evidence of effectiveness exposes patients to substantial downsides." 

Read more

'Our weather is on track to get far more violent and costly'

William S. Becker at The Hill

Inflation dropped last month, but a "new villain has arrived on the scene. Call it 'climate inflation,'" says William S. Becker. "Anyone worried about rising costs of living … should be concerned." Last year, 28 weather disasters cost America $93 billion. But climate change will affect individuals too. As "historic heat waves" threaten Americans, says Becker, the "average price to cool a home will be $719 this summer, up 9% over last year." Extreme weather also raises the cost of food and home insurance and lowers the value of at-risk houses.

Read more